Michael Fucci Net Worth

The estimated Net Worth of Michael Fucci is at least $4.21 Million dollars as of 17 November 2023. Mr. Fucci owns over 7,693 units of Acadia Healthcare Inc stock worth over $4,208,355 and over the last 4 years he sold ACHC stock worth over $0. In addition, he makes $0 as Independent Director at Acadia Healthcare Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Fucci ACHC stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Acadia Healthcare Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 7,693 units of ACHC stock worth $30,003 on 17 November 2023.

The largest trade he's ever made was buying 7,693 units of Acadia Healthcare Inc stock on 17 November 2023 worth over $30,003. On average, Michael trades about 699 units every 0 days since 2020. As of 17 November 2023 he still owns at least 54,576 units of Acadia Healthcare Inc stock.

You can see the complete history of Mr. Fucci stock trades at the bottom of the page.

Michael Fucci biography

Michael J. Fucci serves as Independent Director of the Company. Prior to his retirement in September 2020, Mr. Fucci served as Chairman Emeritus of Deloitte U.S. He previously served as Executive Chairman of Deloitte U.S. from 2015 to 2019, Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held various management positions since 2003. He provided governance and operational leadership for Deloitte U.S. in critical areas such as organization strategy, leadership succession and risk mitigation, as well as executive performance and compensation. Mr. Fucci also served as a member on both the Deloitte U.S. and Deloitte Global Boards of Directors. While at Deloitte U.S., he established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors.

What's Michael Fucci's mailing address?

Michael's mailing address filed with the SEC is 5775 N. SAM HOUSTON PARKWAY W., STE 400, HOUSTON, TX, 77086.

Insiders trading at Acadia Healthcare Inc

Over the last 14 years, insiders at Acadia Healthcare Inc have traded over $2,037,245,357 worth of Acadia Healthcare Inc stock and bought 386,666 units worth $3,280,595 . The most active insiders traders include Christopher R Gordon, Reeve B Waud, and Capital Partners Ii, L.L.C..... On average, Acadia Healthcare Inc executives and independent directors trade stock every 20 days with the average trade being worth of $13,772,232. The most recent stock trade was executed by Wade D Miquelon on 5 March 2024, trading 2,203 units of ACHC stock currently worth $188,114.

What does Acadia Healthcare Inc do?

acadia is a provider of inpatient and outpatient behavioral health and addiction treatment services. acadia operates a network of 225 behavioral healthcare facilities with approximately 9,190 beds in 37 states, the united kingdom and puerto rico. acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. acadia healthcare’s behavioral health treatment facilities are specialized solely in helping children, teenagers and adults suffering from mental health disorders and/or alcohol and drug addiction.

Complete history of Mr. Fucci stock trades at Acadia Healthcare Inc and Flotek Industries Inc

Acadia Healthcare Inc executives and stock owners

Acadia Healthcare Inc executives and other stock owners filed with the SEC include:

• Debra Osteen,
  Chief Executive Officer, Director
• Debra K. Osteen,
  CEO & Director
• John Hollinsworth,
  Executive Vice President of Operations
• Laurence L. Harrod,
  Exec. VP of Fin.
• David Duckworth,
  Chief Financial Officer
• Christopher Howard,
  Executive Vice President, General Counsel, Secretary
• David M. Duckworth,
  Chief Financial Officer
• John S. Hollinsworth,
  Exec. VP of Operations
• Christopher L. Howard,
  Exec. VP, Gen. Counsel & Sec.
• Larry Harrod,
  Executive Vice President - Finance
• Reeve Waud,
  Independent Chairman of the Board
• William Grieco,
  Independent Director
• E. Perot Bissell,
  Independent Director
• Vicky Gregg,
  Independent Director
• Wade Miquelon,
  Independent Director
• William Petrie,
  Independent Director
• Jason Bernhard,
  Independent Director
• Michael Fucci,
  Independent Director
• David M. Keys CFA,
  Chief Devel. Officer
• Dr. Michael Genovese J.D., M.D.,
  Chief Medical Officer
• Isa Diaz,
  Sr. VP of Strategic Affairs
• Dr. Anne Kelly B.S.N., Ed.D.,
  Chief Quality & Compliance Officer
• Gretchen Hommrich,
  Director of Investor Relations
• Hartley R. Rogers,
  Director
• Christopher R Gordon,
  Director
• Scott Schwieger,
  Chief Compliance Officer
• Capital Partners Iii, L.L.C...,
  
• Capital Partners Ii, L.L.C....,
  
• Randall P Goldberg,
  10% owner
• B. Waud 2011 Family Trust R...,
  10% owner
• Heather Brianne Dixon,
  Chief Financial Officer
• Fincher 2011 Grantor Retain...,
  10% owner
• A. Jacobs 2011 Grantor Reta...,
  10% owner
• Danny E Carpenter,
  10% owner
• Fred Thomas Jr Dodd,
  10% owner
• Ronald Morgan Fincher,
  Chief Operating Officer
• Bruce A Shear,
  Executive Vice Chairman
• Joey A Jacobs,
  Chief Executive Officer
• Jack E Polson,
  Chief Financial Officer
• Capital Investors Llcbcip A...,
  
• Kyle D. Lattner,
  Director
• Family Partners, L.P. Waud,
  10% owner
• Capital Investors Llcbain C...,
  
• Capital Partners, L.L.C. Waud,
  10% owner
• Lp Rgip,,
  
• Norman King Iii Carter,
  Co-President
• Matthew W. Clary,
  Director
• Bradley M. Eckmann,
  Director
• Capital Partners Ii, L.L.C....,
  
• David O. Neighbours,
  Director
• Christopher J. Graber,
  Director
• Allan B Hubbard,
  Director
• Healthcare Holdings, Llc Ac...,
  10% owner
• Matthew London,
  Director
• Brent Turner 2011 Grantor R...,
  10% owner
• Brent Turner,
  Co-President
• Karen Marie Prince,
  10% owner
• Eric S. Gordon,
  Director
• Robert Walton Swinson,
  10% owner
• Brian Farley,
  EVP, GC and Secretary
• Ralph David Kelly,
  
• Patrice A Harris,
  
• Christopher H. Hunter,
  Chief Executive Officer
• Laurence L. Harrod,
  EVP of Finance